Click for best price
RNABased Therapeutics Vaccines Market Size, Share 2022
RNA-based biopharmaceuticals, which includes therapeutics and vaccines, is a relatively new class of treatment and prophylactic for a number of chronic and rare diseases, including cancer, diabetes, tuberculosis and certaincardiovascular conditions.
This report contains market size and forecasts of RNA-Based Therapeutics and Vaccines in Global, including the following market information:
The global RNA-Based Therapeutics and Vaccines market was valued at 26 million in 2021 and is projected to reach US$ 558.8 million by 2028, at a CAGR of 54.9% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
RNA-Based Therapeutics Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of RNA-Based Therapeutics and Vaccines include Alnylam Pharmaceuticals, Arbutus Biopharma, Arrowhead Pharmaceuticals, BioNTech, CureVac, Dicerna Pharmaceuticals, Regulus Therapeutics, Marina Biotech and MiRagen Therapeutics, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the RNA-Based Therapeutics and Vaccines companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global RNA-Based Therapeutics and Vaccines Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global RNA-Based Therapeutics and Vaccines Market Segment Percentages, by Type, 2021 (%)
- RNA-Based Therapeutics
- RNA-Based Vaccines
Global RNA-Based Therapeutics and Vaccines Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global RNA-Based Therapeutics and Vaccines Market Segment Percentages, by Application, 2021 (%)
- Oncology
- Immunology
- Ophthalmology
- Cardiovascular Diseases
- Infectious Diseases
- Genetic Diseases
- Others
Global RNA-Based Therapeutics and Vaccines Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global RNA-Based Therapeutics and Vaccines Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies RNA-Based Therapeutics and Vaccines revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies RNA-Based Therapeutics and Vaccines revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Alnylam Pharmaceuticals
- Arbutus Biopharma
- Arrowhead Pharmaceuticals
- BioNTech
- CureVac
- Dicerna Pharmaceuticals
- Regulus Therapeutics
- Marina Biotech
- MiRagen Therapeutics
- Moderna Therapeutics
- Quark Pharmaceuticals
- Roche
- Sylentis
| Report Attributes |
Report Details |
| Report Title |
RNA-Based Therapeutics and Vaccines Market, Global Outlook and Forecast 2022-2028 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2021 |
| Forecast Year |
2029 |
| Number of Pages |
67 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 RNA-Based Therapeutics and Vaccines Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global RNA-Based Therapeutics and Vaccines Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global RNA-Based Therapeutics and Vaccines Overall Market Size
2.1 Global RNA-Based Therapeutics and Vaccines Market Size: 2021 VS 2028
2.2 Global RNA-Based Therapeutics and Vaccines Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top RNA-Based Therapeutics and Vaccines Players in Global Market
3.2 Top Global RNA-Based Therapeutics and Vaccines Companies Ranked by Revenue
3.3 Global RNA-Based Therapeutics and Vaccines Revenue by Companies
3.4 Top 3 and Top 5 RNA-Based Therapeutics and Vaccines Companies in Global Market, by Revenue in 2021
3.5 Global Companies RNA-Based Therapeutics and Vaccines Product Type
3.6 Tier 1, Tier 2 and Tier 3 RNA-Based Therapeutics and Vaccines Players in Global Market
3.6.1 List of Global Tier 1 RNA-Based Therapeutics and Vaccines Companies
3.6.2 List of Global Tier 2 and Tier 3 RNA-Based Therapeutics and Vaccines Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global RNA-Based Therapeutics and Vaccines Market Size Markets, 2021 & 2028
4.1.2 RNA-Based Therapeutics
4.1.3 RNA-Based Vaccines
4.2 By Type - Global RNA-Based Therapeutics and Vaccines Revenue & Forecasts
4.2.1 By Type - Global RNA-Based Therapeutics and Vaccines Revenue, 2017-2022
4.2.2 By Type - Global RNA-Based Therapeutics and Vaccines Revenue, 2023-2028
4.2.3 By Type - Global RNA-Based Therapeutics and Vaccines Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global RNA-Based Therapeutics and Vaccines Market Size, 2021 & 2028
5.1.2 Oncology
5.1.3 Immunology
5.1.4 Ophthalmology
5.1.5 Cardiovascular Diseases
5.1.6 Infectious Diseases
5.1.7 Genetic Diseases
5.1.8 Others
5.2 By Application - Global RNA-Based Therapeutics and Vaccines Revenue & Forecasts
5.2.1 By Application - Global RNA-Based Therapeutics and Vaccines Revenue, 2017-2022
5.2.2 By Application - Global RNA-Based Therapeutics and Vaccines Revenue, 2023-2028
5.2.3 By Application - Global RNA-Based Therapeutics and Vaccines Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global RNA-Based Therapeutics and Vaccines Market Size, 2021 & 2028
6.2 By Region - Global RNA-Based Therapeutics and Vaccines Revenue & Forecasts
6.2.1 By Region - Global RNA-Based Therapeutics and Vaccines Revenue, 2017-2022
6.2.2 By Region - Global RNA-Based Therapeutics and Vaccines Revenue, 2023-2028
6.2.3 By Region - Global RNA-Based Therapeutics and Vaccines Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America RNA-Based Therapeutics and Vaccines Revenue, 2017-2028
6.3.2 US RNA-Based Therapeutics and Vaccines Market Size, 2017-2028
6.3.3 Canada RNA-Based Therapeutics and Vaccines Market Size, 2017-2028
6.3.4 Mexico RNA-Based Therapeutics and Vaccines Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe RNA-Based Therapeutics and Vaccines Revenue, 2017-2028
6.4.2 Germany RNA-Based Therapeutics and Vaccines Market Size, 2017-2028
6.4.3 France RNA-Based Therapeutics and Vaccines Market Size, 2017-2028
6.4.4 U.K. RNA-Based Therapeutics and Vaccines Market Size, 2017-2028
6.4.5 Italy RNA-Based Therapeutics and Vaccines Market Size, 2017-2028
6.4.6 Russia RNA-Based Therapeutics and Vaccines Market Size, 2017-2028
6.4.7 Nordic Countries RNA-Based Therapeutics and Vaccines Market Size, 2017-2028
6.4.8 Benelux RNA-Based Therapeutics and Vaccines Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia RNA-Based Therapeutics and Vaccines Revenue, 2017-2028
6.5.2 China RNA-Based Therapeutics and Vaccines Market Size, 2017-2028
6.5.3 Japan RNA-Based Therapeutics and Vaccines Market Size, 2017-2028
6.5.4 South Korea RNA-Based Therapeutics and Vaccines Market Size, 2017-2028
6.5.5 Southeast Asia RNA-Based Therapeutics and Vaccines Market Size, 2017-2028
6.5.6 India RNA-Based Therapeutics and Vaccines Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America RNA-Based Therapeutics and Vaccines Revenue, 2017-2028
6.6.2 Brazil RNA-Based Therapeutics and Vaccines Market Size, 2017-2028
6.6.3 Argentina RNA-Based Therapeutics and Vaccines Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa RNA-Based Therapeutics and Vaccines Revenue, 2017-2028
6.7.2 Turkey RNA-Based Therapeutics and Vaccines Market Size, 2017-2028
6.7.3 Israel RNA-Based Therapeutics and Vaccines Market Size, 2017-2028
6.7.4 Saudi Arabia RNA-Based Therapeutics and Vaccines Market Size, 2017-2028
6.7.5 UAE RNA-Based Therapeutics and Vaccines Market Size, 2017-2028
7 Players Profiles
7.1 Alnylam Pharmaceuticals
7.1.1 Alnylam Pharmaceuticals Corporate Summary
7.1.2 Alnylam Pharmaceuticals Business Overview
7.1.3 Alnylam Pharmaceuticals RNA-Based Therapeutics and Vaccines Major Product Offerings
7.1.4 Alnylam Pharmaceuticals RNA-Based Therapeutics and Vaccines Revenue in Global Market (2017-2022)
7.1.5 Alnylam Pharmaceuticals Key News
7.2 Arbutus Biopharma
7.2.1 Arbutus Biopharma Corporate Summary
7.2.2 Arbutus Biopharma Business Overview
7.2.3 Arbutus Biopharma RNA-Based Therapeutics and Vaccines Major Product Offerings
7.2.4 Arbutus Biopharma RNA-Based Therapeutics and Vaccines Revenue in Global Market (2017-2022)
7.2.5 Arbutus Biopharma Key News
7.3 Arrowhead Pharmaceuticals
7.3.1 Arrowhead Pharmaceuticals Corporate Summary
7.3.2 Arrowhead Pharmaceuticals Business Overview
7.3.3 Arrowhead Pharmaceuticals RNA-Based Therapeutics and Vaccines Major Product Offerings
7.3.4 Arrowhead Pharmaceuticals RNA-Based Therapeutics and Vaccines Revenue in Global Market (2017-2022)
7.3.5 Arrowhead Pharmaceuticals Key News
7.4 BioNTech
7.4.1 BioNTech Corporate Summary
7.4.2 BioNTech Business Overview
7.4.3 BioNTech RNA-Based Therapeutics and Vaccines Major Product Offerings
7.4.4 BioNTech RNA-Based Therapeutics and Vaccines Revenue in Global Market (2017-2022)
7.4.5 BioNTech Key News
7.5 CureVac
7.5.1 CureVac Corporate Summary
7.5.2 CureVac Business Overview
7.5.3 CureVac RNA-Based Therapeutics and Vaccines Major Product Offerings
7.5.4 CureVac RNA-Based Therapeutics and Vaccines Revenue in Global Market (2017-2022)
7.5.5 CureVac Key News
7.6 Dicerna Pharmaceuticals
7.6.1 Dicerna Pharmaceuticals Corporate Summary
7.6.2 Dicerna Pharmaceuticals Business Overview
7.6.3 Dicerna Pharmaceuticals RNA-Based Therapeutics and Vaccines Major Product Offerings
7.6.4 Dicerna Pharmaceuticals RNA-Based Therapeutics and Vaccines Revenue in Global Market (2017-2022)
7.6.5 Dicerna Pharmaceuticals Key News
7.7 Regulus Therapeutics
7.7.1 Regulus Therapeutics Corporate Summary
7.7.2 Regulus Therapeutics Business Overview
7.7.3 Regulus Therapeutics RNA-Based Therapeutics and Vaccines Major Product Offerings
7.7.4 Regulus Therapeutics RNA-Based Therapeutics and Vaccines Revenue in Global Market (2017-2022)
7.7.5 Regulus Therapeutics Key News
7.8 Marina Biotech
7.8.1 Marina Biotech Corporate Summary
7.8.2 Marina Biotech Business Overview
7.8.3 Marina Biotech RNA-Based Therapeutics and Vaccines Major Product Offerings
7.8.4 Marina Biotech RNA-Based Therapeutics and Vaccines Revenue in Global Market (2017-2022)
7.8.5 Marina Biotech Key News
7.9 MiRagen Therapeutics
7.9.1 MiRagen Therapeutics Corporate Summary
7.9.2 MiRagen Therapeutics Business Overview
7.9.3 MiRagen Therapeutics RNA-Based Therapeutics and Vaccines Major Product Offerings
7.9.4 MiRagen Therapeutics RNA-Based Therapeutics and Vaccines Revenue in Global Market (2017-2022)
7.9.5 MiRagen Therapeutics Key News
7.10 Moderna Therapeutics
7.10.1 Moderna Therapeutics Corporate Summary
7.10.2 Moderna Therapeutics Business Overview
7.10.3 Moderna Therapeutics RNA-Based Therapeutics and Vaccines Major Product Offerings
7.10.4 Moderna Therapeutics RNA-Based Therapeutics and Vaccines Revenue in Global Market (2017-2022)
7.10.5 Moderna Therapeutics Key News
7.11 Quark Pharmaceuticals
7.11.1 Quark Pharmaceuticals Corporate Summary
7.11.2 Quark Pharmaceuticals Business Overview
7.11.3 Quark Pharmaceuticals RNA-Based Therapeutics and Vaccines Major Product Offerings
7.11.4 Quark Pharmaceuticals RNA-Based Therapeutics and Vaccines Revenue in Global Market (2017-2022)
7.11.5 Quark Pharmaceuticals Key News
7.12 Roche
7.12.1 Roche Corporate Summary
7.12.2 Roche Business Overview
7.12.3 Roche RNA-Based Therapeutics and Vaccines Major Product Offerings
7.12.4 Roche RNA-Based Therapeutics and Vaccines Revenue in Global Market (2017-2022)
7.12.5 Roche Key News
7.13 Sylentis
7.13.1 Sylentis Corporate Summary
7.13.2 Sylentis Business Overview
7.13.3 Sylentis RNA-Based Therapeutics and Vaccines Major Product Offerings
7.13.4 Sylentis RNA-Based Therapeutics and Vaccines Revenue in Global Market (2017-2022)
7.13.5 Sylentis Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. RNA-Based Therapeutics and Vaccines Market Opportunities & Trends in Global Market
Table 2. RNA-Based Therapeutics and Vaccines Market Drivers in Global Market
Table 3. RNA-Based Therapeutics and Vaccines Market Restraints in Global Market
Table 4. Key Players of RNA-Based Therapeutics and Vaccines in Global Market
Table 5. Top RNA-Based Therapeutics and Vaccines Players in Global Market, Ranking by Revenue (2021)
Table 6. Global RNA-Based Therapeutics and Vaccines Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global RNA-Based Therapeutics and Vaccines Revenue Share by Companies, 2017-2022
Table 8. Global Companies RNA-Based Therapeutics and Vaccines Product Type
Table 9. List of Global Tier 1 RNA-Based Therapeutics and Vaccines Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 RNA-Based Therapeutics and Vaccines Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type ? Global RNA-Based Therapeutics and Vaccines Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - RNA-Based Therapeutics and Vaccines Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - RNA-Based Therapeutics and Vaccines Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application ? Global RNA-Based Therapeutics and Vaccines Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - RNA-Based Therapeutics and Vaccines Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - RNA-Based Therapeutics and Vaccines Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region ? Global RNA-Based Therapeutics and Vaccines Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global RNA-Based Therapeutics and Vaccines Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global RNA-Based Therapeutics and Vaccines Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America RNA-Based Therapeutics and Vaccines Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America RNA-Based Therapeutics and Vaccines Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe RNA-Based Therapeutics and Vaccines Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe RNA-Based Therapeutics and Vaccines Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia RNA-Based Therapeutics and Vaccines Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia RNA-Based Therapeutics and Vaccines Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America RNA-Based Therapeutics and Vaccines Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America RNA-Based Therapeutics and Vaccines Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa RNA-Based Therapeutics and Vaccines Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa RNA-Based Therapeutics and Vaccines Revenue, (US$, Mn), 2023-2028
Table 30. Alnylam Pharmaceuticals Corporate Summary
Table 31. Alnylam Pharmaceuticals RNA-Based Therapeutics and Vaccines Product Offerings
Table 32. Alnylam Pharmaceuticals RNA-Based Therapeutics and Vaccines Revenue (US$, Mn), (2017-2022)
Table 33. Arbutus Biopharma Corporate Summary
Table 34. Arbutus Biopharma RNA-Based Therapeutics and Vaccines Product Offerings
Table 35. Arbutus Biopharma RNA-Based Therapeutics and Vaccines Revenue (US$, Mn), (2017-2022)
Table 36. Arrowhead Pharmaceuticals Corporate Summary
Table 37. Arrowhead Pharmaceuticals RNA-Based Therapeutics and Vaccines Product Offerings
Table 38. Arrowhead Pharmaceuticals RNA-Based Therapeutics and Vaccines Revenue (US$, Mn), (2017-2022)
Table 39. BioNTech Corporate Summary
Table 40. BioNTech RNA-Based Therapeutics and Vaccines Product Offerings
Table 41. BioNTech RNA-Based Therapeutics and Vaccines Revenue (US$, Mn), (2017-2022)
Table 42. CureVac Corporate Summary
Table 43. CureVac RNA-Based Therapeutics and Vaccines Product Offerings
Table 44. CureVac RNA-Based Therapeutics and Vaccines Revenue (US$, Mn), (2017-2022)
Table 45. Dicerna Pharmaceuticals Corporate Summary
Table 46. Dicerna Pharmaceuticals RNA-Based Therapeutics and Vaccines Product Offerings
Table 47. Dicerna Pharmaceuticals RNA-Based Therapeutics and Vaccines Revenue (US$, Mn), (2017-2022)
Table 48. Regulus Therapeutics Corporate Summary
Table 49. Regulus Therapeutics RNA-Based Therapeutics and Vaccines Product Offerings
Table 50. Regulus Therapeutics RNA-Based Therapeutics and Vaccines Revenue (US$, Mn), (2017-2022)
Table 51. Marina Biotech Corporate Summary
Table 52. Marina Biotech RNA-Based Therapeutics and Vaccines Product Offerings
Table 53. Marina Biotech RNA-Based Therapeutics and Vaccines Revenue (US$, Mn), (2017-2022)
Table 54. MiRagen Therapeutics Corporate Summary
Table 55. MiRagen Therapeutics RNA-Based Therapeutics and Vaccines Product Offerings
Table 56. MiRagen Therapeutics RNA-Based Therapeutics and Vaccines Revenue (US$, Mn), (2017-2022)
Table 57. Moderna Therapeutics Corporate Summary
Table 58. Moderna Therapeutics RNA-Based Therapeutics and Vaccines Product Offerings
Table 59. Moderna Therapeutics RNA-Based Therapeutics and Vaccines Revenue (US$, Mn), (2017-2022)
Table 60. Quark Pharmaceuticals Corporate Summary
Table 61. Quark Pharmaceuticals RNA-Based Therapeutics and Vaccines Product Offerings
Table 62. Quark Pharmaceuticals RNA-Based Therapeutics and Vaccines Revenue (US$, Mn), (2017-2022)
Table 63. Roche Corporate Summary
Table 64. Roche RNA-Based Therapeutics and Vaccines Product Offerings
Table 65. Roche RNA-Based Therapeutics and Vaccines Revenue (US$, Mn), (2017-2022)
Table 66. Sylentis Corporate Summary
Table 67. Sylentis RNA-Based Therapeutics and Vaccines Product Offerings
Table 68. Sylentis RNA-Based Therapeutics and Vaccines Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. RNA-Based Therapeutics and Vaccines Segment by Type in 2021
Figure 2. RNA-Based Therapeutics and Vaccines Segment by Application in 2021
Figure 3. Global RNA-Based Therapeutics and Vaccines Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global RNA-Based Therapeutics and Vaccines Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global RNA-Based Therapeutics and Vaccines Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by RNA-Based Therapeutics and Vaccines Revenue in 2021
Figure 8. By Type - Global RNA-Based Therapeutics and Vaccines Revenue Market Share, 2017-2028
Figure 9. By Application - Global RNA-Based Therapeutics and Vaccines Revenue Market Share, 2017-2028
Figure 10. By Region - Global RNA-Based Therapeutics and Vaccines Revenue Market Share, 2017-2028
Figure 11. By Country - North America RNA-Based Therapeutics and Vaccines Revenue Market Share, 2017-2028
Figure 12. US RNA-Based Therapeutics and Vaccines Revenue, (US$, Mn), 2017-2028
Figure 13. Canada RNA-Based Therapeutics and Vaccines Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico RNA-Based Therapeutics and Vaccines Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe RNA-Based Therapeutics and Vaccines Revenue Market Share, 2017-2028
Figure 16. Germany RNA-Based Therapeutics and Vaccines Revenue, (US$, Mn), 2017-2028
Figure 17. France RNA-Based Therapeutics and Vaccines Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. RNA-Based Therapeutics and Vaccines Revenue, (US$, Mn), 2017-2028
Figure 19. Italy RNA-Based Therapeutics and Vaccines Revenue, (US$, Mn), 2017-2028
Figure 20. Russia RNA-Based Therapeutics and Vaccines Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries RNA-Based Therapeutics and Vaccines Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux RNA-Based Therapeutics and Vaccines Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia RNA-Based Therapeutics and Vaccines Revenue Market Share, 2017-2028
Figure 24. China RNA-Based Therapeutics and Vaccines Revenue, (US$, Mn), 2017-2028
Figure 25. Japan RNA-Based Therapeutics and Vaccines Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea RNA-Based Therapeutics and Vaccines Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia RNA-Based Therapeutics and Vaccines Revenue, (US$, Mn), 2017-2028
Figure 28. India RNA-Based Therapeutics and Vaccines Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America RNA-Based Therapeutics and Vaccines Revenue Market Share, 2017-2028
Figure 30. Brazil RNA-Based Therapeutics and Vaccines Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina RNA-Based Therapeutics and Vaccines Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa RNA-Based Therapeutics and Vaccines Revenue Market Share, 2017-2028
Figure 33. Turkey RNA-Based Therapeutics and Vaccines Revenue, (US$, Mn), 2017-2028
Figure 34. Israel RNA-Based Therapeutics and Vaccines Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia RNA-Based Therapeutics and Vaccines Revenue, (US$, Mn), 2017-2028
Figure 36. UAE RNA-Based Therapeutics and Vaccines Revenue, (US$, Mn), 2017-2028
Figure 37. Alnylam Pharmaceuticals RNA-Based Therapeutics and Vaccines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Arbutus Biopharma RNA-Based Therapeutics and Vaccines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Arrowhead Pharmaceuticals RNA-Based Therapeutics and Vaccines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. BioNTech RNA-Based Therapeutics and Vaccines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. CureVac RNA-Based Therapeutics and Vaccines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Dicerna Pharmaceuticals RNA-Based Therapeutics and Vaccines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Regulus Therapeutics RNA-Based Therapeutics and Vaccines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Marina Biotech RNA-Based Therapeutics and Vaccines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. MiRagen Therapeutics RNA-Based Therapeutics and Vaccines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Moderna Therapeutics RNA-Based Therapeutics and Vaccines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Quark Pharmaceuticals RNA-Based Therapeutics and Vaccines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Roche RNA-Based Therapeutics and Vaccines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Sylentis RNA-Based Therapeutics and Vaccines Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
